DE69805787T2 - Verbindungen zur hemmung der magensäuresekretion - Google Patents

Verbindungen zur hemmung der magensäuresekretion

Info

Publication number
DE69805787T2
DE69805787T2 DE69805787T DE69805787T DE69805787T2 DE 69805787 T2 DE69805787 T2 DE 69805787T2 DE 69805787 T DE69805787 T DE 69805787T DE 69805787 T DE69805787 T DE 69805787T DE 69805787 T2 DE69805787 T2 DE 69805787T2
Authority
DE
Germany
Prior art keywords
compounds
acid gas
inhibit acid
secretion
gas secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69805787T
Other languages
German (de)
English (en)
Other versions
DE69805787D1 (de
Inventor
Kosrat Amin
Mikael Dahlstroem
Peter Nordberg
Ingemar Starke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE69805787D1 publication Critical patent/DE69805787D1/de
Application granted granted Critical
Publication of DE69805787T2 publication Critical patent/DE69805787T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69805787T 1997-02-25 1998-02-17 Verbindungen zur hemmung der magensäuresekretion Expired - Fee Related DE69805787T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9700661A SE9700661D0 (sv) 1997-02-25 1997-02-25 New compounds
PCT/SE1998/000275 WO1998037080A1 (en) 1997-02-25 1998-02-17 Compounds for inhibition of gastric acid secretion

Publications (2)

Publication Number Publication Date
DE69805787D1 DE69805787D1 (de) 2002-07-11
DE69805787T2 true DE69805787T2 (de) 2003-01-02

Family

ID=20405920

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69805787T Expired - Fee Related DE69805787T2 (de) 1997-02-25 1998-02-17 Verbindungen zur hemmung der magensäuresekretion

Country Status (33)

Country Link
US (1) US6265415B1 (xx)
EP (1) EP0971920B1 (xx)
JP (1) JP2001512477A (xx)
KR (1) KR20000075622A (xx)
CN (1) CN1100056C (xx)
AR (1) AR011134A1 (xx)
AT (1) ATE218569T1 (xx)
AU (1) AU723389B2 (xx)
BR (1) BR9807457A (xx)
CA (1) CA2280008A1 (xx)
CZ (1) CZ291681B6 (xx)
DE (1) DE69805787T2 (xx)
DK (1) DK0971920T3 (xx)
EE (1) EE04016B1 (xx)
ES (1) ES2178169T3 (xx)
HK (1) HK1024248A1 (xx)
HU (1) HUP0000720A3 (xx)
ID (1) ID22218A (xx)
IL (1) IL131122A0 (xx)
IS (1) IS1901B (xx)
MY (1) MY118822A (xx)
NO (1) NO313009B1 (xx)
NZ (1) NZ336878A (xx)
PL (1) PL190379B1 (xx)
PT (1) PT971920E (xx)
RU (1) RU2193036C2 (xx)
SE (1) SE9700661D0 (xx)
SK (1) SK283903B6 (xx)
TR (1) TR199902060T2 (xx)
TW (1) TW568907B (xx)
UA (1) UA64741C2 (xx)
WO (1) WO1998037080A1 (xx)
ZA (1) ZA981134B (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014084312A1 (ja) * 2012-11-30 2014-06-05 アステラス製薬株式会社 イミダゾピリジン化合物

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141244B1 (en) * 1992-03-02 2006-11-28 Chiron Srl Helicobacter pylori proteins useful for vaccines and diagnostics
EP0769018B1 (en) * 1994-07-01 2002-12-18 Chiron Corporation Helicobacter proteins and vaccines
WO1997025429A1 (en) * 1996-01-04 1997-07-17 Rican Limited Helicobacter pylori bacterioferritin
SE9602286D0 (sv) 1996-06-10 1996-06-10 Astra Ab New compounds
SE9704404D0 (sv) 1997-11-28 1997-11-28 Astra Ab New compounds
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
DE10001037C1 (de) * 2000-01-13 2001-12-13 Byk Gulden Lomberg Chem Fab Verfahren und Zwischenprodukte zur Herstellung von Imidazopyridinen
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
EP1423142A1 (en) * 2001-08-31 2004-06-02 Chiron SRL. Helicobacter pylori vaccination with a combination of caga, vaca and nap proteins
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
ATE378336T1 (de) 2002-09-19 2007-11-15 Schering Corp Imidazopyridine als hemmstoffe cyclin abhängiger kinasen
NZ541861A (en) * 2003-02-26 2009-05-31 Sugen Inc Aminoheteroaryl compounds as protein kinase inhibitors
ME00524B (me) 2003-03-10 2011-10-10 Astrazeneca Ab Novi postupak za dobijanje roflumilasta
US20060194782A1 (en) * 2003-09-18 2006-08-31 Altana Pharma Ag Pharmacologically active imidazo[4,5-c] pyridines
CN1874772A (zh) 2003-11-03 2006-12-06 阿斯利康(瑞典)有限公司 治疗隐匿性胃食管反流的咪唑并[1,2－a]吡啶衍生物
US20070293532A1 (en) * 2004-07-28 2007-12-20 Takeda Pharmaceutical Compan6Y Limited Pyrrolo [2,3-C] Pyridine Compound, Process for Producing the Same, and Use
CN101018788B (zh) 2004-09-03 2010-08-25 株式会社柳韩洋行 吡咯并[3,2-c]吡啶衍生物及其制备方法
EP1784403B1 (en) 2004-09-03 2013-07-17 Yuhan Corporation Pyrrolo[3,2-b]pyridine derivatives and processes for the preparation thereof
KR100958829B1 (ko) 2004-09-03 2010-05-25 주식회사유한양행 피롤로[2,3-ｃ]피리딘 유도체 및 그의 제조방법
KR101068355B1 (ko) * 2005-03-09 2011-09-28 주식회사유한양행 신규의 이미다조[1,2-ａ]피리딘 유도체 및 그의 제조방법
WO2006097456A1 (en) * 2005-03-16 2006-09-21 Nycomed Gmbh Taste masked dosage form containing roflumilast
WO2006100119A1 (en) * 2005-03-24 2006-09-28 Glaxo Group Limited Derivatives of imidazo (1,2-a) pyridine useful as medicaments for treating gastrointestinal diseases
SI1959955T1 (sl) 2005-12-05 2011-02-28 Pfizer Prod Inc Postopek zdravljenja abnormalne celične rasti
WO2007066185A2 (en) 2005-12-05 2007-06-14 Pfizer Products Inc. Polymorphs of a c-met/hgfr inhibitor
CN110483499A (zh) * 2009-11-05 2019-11-22 圣母大学 咪唑并[1,2-a]吡啶类化合物及其合成及使用方法
EA201391769A1 (ru) 2011-05-30 2014-04-30 Астеллас Фарма Инк. Имидазопиридиновые соединения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014084312A1 (ja) * 2012-11-30 2014-06-05 アステラス製薬株式会社 イミダゾピリジン化合物

Also Published As

Publication number Publication date
WO1998037080A1 (en) 1998-08-27
RU2193036C2 (ru) 2002-11-20
NZ336878A (en) 2001-05-25
HUP0000720A3 (en) 2001-01-29
DE69805787D1 (de) 2002-07-11
DK0971920T3 (da) 2002-09-16
SK283903B6 (sk) 2004-04-06
MY118822A (en) 2005-01-31
ID22218A (id) 1999-09-16
ES2178169T3 (es) 2002-12-16
IS1901B (is) 2003-11-20
KR20000075622A (ko) 2000-12-26
CZ291681B6 (cs) 2003-04-16
AU723389B2 (en) 2000-08-24
CA2280008A1 (en) 1998-08-27
MX9907650A (es) 2002-12-13
PT971920E (pt) 2002-11-29
EE9900367A (et) 2000-04-17
TR199902060T2 (xx) 2000-02-21
PL335485A1 (en) 2000-04-25
BR9807457A (pt) 2000-04-25
EP0971920A1 (en) 2000-01-19
AU6314798A (en) 1998-09-09
EP0971920B1 (en) 2002-06-05
HUP0000720A2 (hu) 2000-10-28
TW568907B (en) 2004-01-01
AR011134A1 (es) 2000-08-02
ZA981134B (en) 1998-08-25
IL131122A0 (en) 2001-01-28
CZ301499A3 (cs) 2000-02-16
CN1100056C (zh) 2003-01-29
NO313009B1 (no) 2002-07-29
SK109999A3 (en) 2000-01-18
PL190379B1 (pl) 2005-12-30
EE04016B1 (et) 2003-04-15
HK1024248A1 (en) 2000-10-05
JP2001512477A (ja) 2001-08-21
US6265415B1 (en) 2001-07-24
CN1248257A (zh) 2000-03-22
NO994078L (no) 1999-08-24
NO994078D0 (no) 1999-08-24
ATE218569T1 (de) 2002-06-15
UA64741C2 (uk) 2004-03-15
IS5148A (is) 1999-08-05
SE9700661D0 (sv) 1997-02-25

Similar Documents

Publication Publication Date Title
DE69805787D1 (de) Verbindungen zur hemmung der magensäuresekretion
DE69918278D1 (de) Substituierte indolalkansäure
ATE310009T1 (de) Reaktionssysteme zur herstellung von n- (phosphonomethyl)glyzin verbindungen
ATE303131T1 (de) Zusammensetzungen zur nasalen verabreichung
DE69931249D1 (de) Pflanzliche promotorsequenz aus plastiden
ATE311887T1 (de) Diphosphonsäure enthaltende zusammensetzungen
PT900270E (pt) Composicao acida espessada
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
DE69520056T2 (de) Verbindungen zur Hemmung von Thrombin
DE69715801T2 (de) Granuläre Zusammensetzungen von E-pthalimido-Peroxyhexansäure
IS5845A (is) Aukinn stöðugleiki lausna til inndælingar
NO992853D0 (no) Sulfonsyre- eller sulfonylamino-N-(heteroaralkyl)-azaheterocyklylamidforbindelser
ATE266392T1 (de) Amine zur herstellung von medikamenten zur hemmung der tumorzellenvermehrung
DE69520055T2 (de) Verbindungen zur Hemmung der Thrombin
ATE303153T1 (de) Ibandroinsäure zur förderung der osseointegration der endoprothesen
PT1228026E (pt) Compostos relacionados com o acido 15-hidroxieicosatetraenoico
ID24327A (id) Produksi senyawa-senyawa avermektin
DE69715479T2 (de) Düngemittel-Zusammensetzung zur Verbesserung der Stickstoffwirksamkeit
ID27729A (id) Komposisi-komposisi anti-enzim yang mengandung asam etilendiamin disuksinat
DE60013644D1 (de) Verfahren zur Reinigung von Phosphinoxiden
ID20927A (id) Saluran ke bawah untuk senyawa pada menara proses kimia
ID24694A (id) Pemakaian bentuk zat-zat sebagai katalis untuk pembuatan kaprolaktam
DK0965586T3 (da) Fremgangsmåde til oprensning af carbazolesterforstadier til 6-chlor-alfa-methyl-carbazol-2-eddikesyre
DE59802707D1 (de) Schaltungsanordnung zur zweidraht-vierdraht-umsetzung
PL331398A1 (en) Method of purifying crude salicylic acid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee